Literature DB >> 33685998

SARS-CoV-2 vaccines in patients with SLE.

Wei Tang1, Anca D Askanase2, Leila Khalili1, Joan T Merrill3.   

Abstract

As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  inflammation; lupus erythematosus; systemic; vaccination

Year:  2021        PMID： 33685998     DOI： 10.1136/lupus-2021-000479

Source DB:  PubMed          Journal:  Lupus Sci Med        ISSN： 2053-8790


  13 in total

1.  Self-Reported COVID-19 Vaccines' Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study.

Authors:  Lama T AlMutairi; Wesal Y Alalayet; Sondus I Ata; Khalidah A Alenzi; Yazed AlRuthia
Journal:  Vaccines (Basel)       Date:  2022-06-20

2.  Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.

Authors:  Adrienne K Joseph; Benjamin F Chong
Journal:  Dermatol Ther       Date:  2021-09-06       Impact factor: 3.858

Review 3.  The Use of COVID-19 Vaccines in Patients with SLE.

Authors:  Wei Tang; Yevgeniya Gartshteyn; Edd Ricker; Sean Inzerillo; Shane Murray; Leila Khalili; Anca Askanase
Journal:  Curr Rheumatol Rep       Date:  2021-11-12       Impact factor: 4.592

Review 4.  COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis.

Authors:  Bohdana Doskaliuk; Roman Yatsyshyn; Iryna Klishch; Olena Zimba
Journal:  Rheumatol Int       Date:  2021-10-01       Impact factor: 2.631

5.  Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.

Authors:  Dennis Niebel; Veronika Ralser-Isselstein; Kristel Jaschke; Christine Braegelmann; Thomas Bieber; Joerg Wenzel
Journal:  Dermatol Ther       Date:  2021-06-08       Impact factor: 3.858

6.  An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Vitor Cavalcanti Trindade; Magda Carneiro-Sampaio; Eloisa Bonfa; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-07-10       Impact factor: 3.022

7.  Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.

Authors:  A Kreuter; S-N Burmann; B Burkert; F Oellig; A-L Michalowitz
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 9.228

8.  BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.

Authors:  Quentin Moyon; Delphine Sterlin; Makoto Miyara; François Anna; Guy Gorochov; Zahir Amoura; Alexis Mathian; Raphael Lhote; Pascale Ghillani-Dalbin; Paul Breillat; Sasi Mudumba; Sophia de Alba; Fleur Cohen-Aubart; Julien Haroche; Micheline Pha; Thi Huong Du Boutin; Hedi Chaieb; Pedro Macedo Flores; Pierre Charneau
Journal:  Ann Rheum Dis       Date:  2021-10-04       Impact factor: 19.103

9.  Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.

Authors:  Peter M Izmirly; Mimi Y Kim; Marie Samanovic; Ruth Fernandez-Ruiz; Sharon Ohana; Kristina K Deonaraine; Alexis J Engel; Mala Masson; Xianhong Xie; Amber R Cornelius; Ramin S Herati; Rebecca H Haberman; Jose U Scher; Allison Guttmann; Rebecca B Blank; Benjamin Plotz; Mayce Haj-Ali; Brittany Banbury; Sara Stream; Ghadeer Hasan; Gary Ho; Paula Rackoff; Ashira D Blazer; Chung-E Tseng; H Michael Belmont; Amit Saxena; Mark J Mulligan; Robert M Clancy; Jill P Buyon
Journal:  Arthritis Rheumatol       Date:  2021-12-28       Impact factor: 15.483

10.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Authors:  Nevin Hammam; Samar Tharwat; Rawhya R El Shereef; Ahmed M Elsaman; Noha M Khalil; Hanan M Fathi; Mohamed N Salem; Hanan M El-Saadany; Nermeen Samy; Amany S El-Bahnasawy; Yousra H Abdel-Fattah; Marwa A Amer; Emad ElShebini; Amira T El-Shanawany; Dina H El-Hammady; Rasha Abdel Noor; Marwa ElKhalifa; Faten Ismail; Rasha M Fawzy; Amany R El-Najjar; Zahraa I Selim; Nouran M Abaza; Ahmed R Radwan; Mervat IAbd Elazeem; Wael Abdel Mohsen; Abdel Hafeez Moshrif; Eman F Mohamed; Loay I Aglan; Soha Senara; Maha E Ibrahim; Iman Khalifa; Rasha El Owaidy; Noha El Fakharany; Reem Hamdy A Mohammed; Tamer A Gheita
Journal:  Rheumatol Int       Date:  2021-07-09       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.